The combination treatment of resveratrol and temozolomide demonstrates synergistic effects by inhibiting MGMT expression and downregulating the STAT3/Bcl-2/survivin signaling pathway, which leads to increased apoptosis and cell cycle arrest in glioma cells [243]. The gene discussed is BCL2; the disease is central nervous system cancer.